vs
Apellis Pharmaceuticals, Inc.（APLS）与MARTEN TRANSPORT LTD（MRTN）财务数据对比。点击上方公司名可切换其他公司
MARTEN TRANSPORT LTD的季度营收约是Apellis Pharmaceuticals, Inc.的1.1倍（$210.1M vs $199.9M），MARTEN TRANSPORT LTD净利率更高（1.8% vs -29.5%，领先31.2%），Apellis Pharmaceuticals, Inc.同比增速更快（-5.9% vs -8.8%），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -8.3%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Marten Transport Ltd是一家总部位于美国威斯康星州蒙多维的公路货运企业，主营业务覆盖美国、加拿大和墨西哥地区，提供冷藏货运和干货厢式货运服务。
APLS vs MRTN — 直观对比
营收规模更大
MRTN
是对方的1.1倍
$199.9M
营收增速更快
APLS
高出2.9%
-8.8%
净利率更高
MRTN
高出31.2%
-29.5%
两年增速更快
APLS
近两年复合增速
-8.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $210.1M |
| 净利润 | $-59.0M | $3.7M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 2.2% |
| 净利率 | -29.5% | 1.8% |
| 营收同比 | -5.9% | -8.8% |
| 净利润同比 | -62.2% | -34.4% |
| 每股收益（稀释后） | $-0.40 | $0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSMRTN
| Q4 25 | $199.9M | $210.1M | ||
| Q3 25 | $458.6M | $220.5M | ||
| Q2 25 | $178.5M | $229.9M | ||
| Q1 25 | $166.8M | $223.2M | ||
| Q4 24 | $212.5M | $230.4M | ||
| Q3 24 | $196.8M | $237.4M | ||
| Q2 24 | $199.7M | $246.2M | ||
| Q1 24 | $172.3M | $249.7M |
净利润APLSMRTN
| Q4 25 | $-59.0M | $3.7M | ||
| Q3 25 | $215.7M | $2.2M | ||
| Q2 25 | $-42.2M | $7.2M | ||
| Q1 25 | $-92.2M | $4.3M | ||
| Q4 24 | $-36.4M | $5.6M | ||
| Q3 24 | $-57.4M | $3.8M | ||
| Q2 24 | $-37.7M | $7.9M | ||
| Q1 24 | $-66.4M | $9.6M |
营业利润率APLSMRTN
| Q4 25 | -25.6% | 2.2% | ||
| Q3 25 | 48.7% | 1.2% | ||
| Q2 25 | -18.6% | 4.2% | ||
| Q1 25 | -50.0% | 2.6% | ||
| Q4 24 | -12.3% | 2.9% | ||
| Q3 24 | -24.0% | 1.8% | ||
| Q2 24 | -14.7% | 4.1% | ||
| Q1 24 | -36.0% | 4.9% |
净利率APLSMRTN
| Q4 25 | -29.5% | 1.8% | ||
| Q3 25 | 47.0% | 1.0% | ||
| Q2 25 | -23.6% | 3.1% | ||
| Q1 25 | -55.3% | 1.9% | ||
| Q4 24 | -17.1% | 2.4% | ||
| Q3 24 | -29.2% | 1.6% | ||
| Q2 24 | -18.9% | 3.2% | ||
| Q1 24 | -38.5% | 3.9% |
每股收益（稀释后）APLSMRTN
| Q4 25 | $-0.40 | $0.04 | ||
| Q3 25 | $1.67 | $0.03 | ||
| Q2 25 | $-0.33 | $0.09 | ||
| Q1 25 | $-0.74 | $0.05 | ||
| Q4 24 | $-0.30 | $0.06 | ||
| Q3 24 | $-0.46 | $0.05 | ||
| Q2 24 | $-0.30 | $0.10 | ||
| Q1 24 | $-0.54 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $43.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $767.6M |
| 总资产 | $1.1B | $949.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSMRTN
| Q4 25 | $466.2M | $43.3M | ||
| Q3 25 | $479.2M | $49.5M | ||
| Q2 25 | $370.0M | $35.1M | ||
| Q1 25 | $358.4M | $39.9M | ||
| Q4 24 | $411.3M | $17.3M | ||
| Q3 24 | $396.9M | $43.0M | ||
| Q2 24 | $360.1M | $77.2M | ||
| Q1 24 | $325.9M | $73.7M |
总债务APLSMRTN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSMRTN
| Q4 25 | $370.1M | $767.6M | ||
| Q3 25 | $401.2M | $768.2M | ||
| Q2 25 | $156.3M | $770.7M | ||
| Q1 25 | $164.2M | $767.5M | ||
| Q4 24 | $228.5M | $767.9M | ||
| Q3 24 | $237.1M | $766.5M | ||
| Q2 24 | $264.3M | $766.8M | ||
| Q1 24 | $266.7M | $762.4M |
总资产APLSMRTN
| Q4 25 | $1.1B | $949.8M | ||
| Q3 25 | $1.1B | $975.7M | ||
| Q2 25 | $821.4M | $991.8M | ||
| Q1 25 | $807.3M | $983.3M | ||
| Q4 24 | $885.1M | $968.8M | ||
| Q3 24 | $901.9M | $1.0B | ||
| Q2 24 | $904.5M | $1.0B | ||
| Q1 24 | $831.9M | $993.0M |
负债/权益比APLSMRTN
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $5.6M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 1.51× |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSMRTN
| Q4 25 | $-14.2M | $5.6M | ||
| Q3 25 | $108.5M | $18.5M | ||
| Q2 25 | $4.4M | $33.2M | ||
| Q1 25 | $-53.4M | $36.2M | ||
| Q4 24 | $19.4M | $23.8M | ||
| Q3 24 | $34.1M | $29.5M | ||
| Q2 24 | $-8.3M | $35.8M | ||
| Q1 24 | $-133.0M | $45.7M |
自由现金流APLSMRTN
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-8.4M | — | ||
| Q1 24 | $-133.3M | — |
自由现金流率APLSMRTN
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | — | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -4.2% | — | ||
| Q1 24 | -77.3% | — |
资本支出强度APLSMRTN
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.2% | — |
现金转化率APLSMRTN
| Q4 25 | — | 1.51× | ||
| Q3 25 | 0.50× | 8.33× | ||
| Q2 25 | — | 4.61× | ||
| Q1 25 | — | 8.35× | ||
| Q4 24 | — | 4.22× | ||
| Q3 24 | — | 7.85× | ||
| Q2 24 | — | 4.54× | ||
| Q1 24 | — | 4.74× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
MRTN
| Revenue Net Of Fuel Surcharge | $91.2M | 43% |
| Dedicated | $65.9M | 31% |
| Brokerage | $38.2M | 18% |
| Truckload Fuel Surcharge Revenue | $14.8M | 7% |
| Fuel Surcharge Revenue | $9.8M | 5% |
